These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23433323)

  • 1. 17 OHPC for prevention of preterm birth in twins: back to the drawing board?
    Durnwald CP
    Am J Obstet Gynecol; 2013 Mar; 208(3):167-8. PubMed ID: 23433323
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality related to 17-OHPC exposure is an important safety outcome.
    O'Brien JM
    Am J Obstet Gynecol; 2013 Sep; 209(3):282-3. PubMed ID: 23628265
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: To PMID 23433324.
    Senat MV; Rozenberg P
    Am J Obstet Gynecol; 2013 Sep; 209(3):283-4. PubMed ID: 23628261
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial.
    Senat MV; Porcher R; Winer N; Vayssière C; Deruelle P; Capelle M; Bretelle F; Perrotin F; Laurent Y; Connan L; Langer B; Mantel A; Azimi S; Rozenberg P;
    Am J Obstet Gynecol; 2013 Mar; 208(3):194.e1-8. PubMed ID: 23433324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17-alpha-hydroprogesterone caproate and cervical changes.
    Facchinetti F
    Am J Obstet Gynecol; 2010 Sep; 203(3):e9; author reply e10. PubMed ID: 20537309
    [No Abstract]   [Full Text] [Related]  

  • 6. Is 17α-hydroxyprogesterone caproate contraindicated in twin gestations?
    Romero R; Conde-Agudelo A
    BJOG; 2015 Jan; 122(1):6-7. PubMed ID: 25280114
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
    Rafael TJ; Mackeen AD; Berghella V
    Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. There is still insufficient data to recommend screening twin pregnancies with transvaginal ultrasound cervical length, but this might change soon!
    Gimovsky A; Berghella V
    BJOG; 2015 Jan; 122(1):38. PubMed ID: 25145404
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time.
    Durnwald CP; Lynch CD; Walker H; Iams JD
    Am J Obstet Gynecol; 2009 Oct; 201(4):410.e1-5. PubMed ID: 19716117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.
    Feghali M; Venkataramanan R; Caritis S
    Semin Perinatol; 2014 Dec; 38(8):516-22. PubMed ID: 25256193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone and preterm birth.
    O'Brien JM
    N Engl J Med; 2007 Nov; 357(22):2306; author reply 2307. PubMed ID: 18050514
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies.
    Lim AC; Schuit E; Papatsonis D; van Eyck J; Porath MM; van Oirschot CM; Hummel P; Hasaart TH; Kleiverda G; de Graaf IM; van Ginkel AA; Mol BW; Bruinse HW
    Ultrasound Obstet Gynecol; 2012 Oct; 40(4):426-30. PubMed ID: 23008102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth.
    Society for Maternal-Fetal Medicine (SMFM) Publications Committee
    Am J Obstet Gynecol; 2017 Mar; 216(3):B11-B13. PubMed ID: 28126367
    [No Abstract]   [Full Text] [Related]  

  • 15. Are we stopping preterm birth trials too early?
    Byrne R; Mol B
    Am J Obstet Gynecol; 2016 Jan; 214(1):134-5. PubMed ID: 26363485
    [No Abstract]   [Full Text] [Related]  

  • 16. Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproate.
    Combs CA; Garite TJ; Maurel K; Das A;
    Am J Perinatol; 2014 Dec; 31(12):1023-30. PubMed ID: 24566755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What use of progesterone to prevent preterm birth?].
    Legardeur H; Mandelbrot L; Kayem G
    Gynecol Obstet Fertil; 2013; 41(7-8):459-64. PubMed ID: 23876420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of progestogens for the prevention of premature birth.
    Schindler AE
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):435-8. PubMed ID: 16198556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing preterm births.
    Reprod Biomed Online; 2007 May; 14(5):663. PubMed ID: 17509212
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
    Awwad J; Usta IM; Ghazeeri G; Yacoub N; Succar J; Hayek S; Saasouh W; Nassar AH
    BJOG; 2015 Jan; 122(1):71-9. PubMed ID: 25163819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.